相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Agonist-Trafficking and Hallucinogens
Javier Gonzalez-Maeso et al.
CURRENT MEDICINAL CHEMISTRY (2009)
The behavioral pharmacology of hallucinogens
William E. Fantegrossi et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Simultaneous inference in general parametric models
Torsten Hothorn et al.
BIOMETRICAL JOURNAL (2008)
Hallucinogen-induced psychological disorders
L. Hermle et al.
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE (2008)
Human hallucinogen research: guidelines for safety
M. W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
R. R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Identification of a serotonin/glutamate receptor complex implicated in psychosis
Javier Gonzalez-Maeso et al.
NATURE (2008)
Effects of varied doses of psilocybin on time interval reproduction in human subjects
Jiri Wackermann et al.
NEUROSCIENCE LETTERS (2008)
Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis
Karsten Heekeren et al.
PSYCHOPHARMACOLOGY (2008)
Serotonin research: contributions to understanding psychoses
Mark A. Geyer et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans
Olivia L. Carter et al.
PSYCHOPHARMACOLOGY (2007)
The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval
Franz X. Vollenweider et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior
Javier Gonzalez-Maeso et al.
NEURON (2007)
Effects of psilocybin on time perception and temporal control of behaviour in humans
Marc Wittmann et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
Francisco A. Moreno et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
R. R. Griffiths et al.
PSYCHOPHARMACOLOGY (2006)
Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors
OL Carter et al.
JOURNAL OF COGNITIVE NEUROSCIENCE (2005)
Hallucinogen persisting perception disorder after psilocybin consumption: a case study
ML Espiard et al.
EUROPEAN PSYCHIATRY (2005)
Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin
OL Carter et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study
F Hasler et al.
PSYCHOPHARMACOLOGY (2004)
Psilocybin impairs high-level but not low-level motion perception
OL Carter et al.
NEUROREPORT (2004)
Hallucinogen persisting perception disorder: what do we know after 50 years?
JH Halpern et al.
DRUG AND ALCOHOL DEPENDENCE (2003)
Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: Implications for the neuropharmacology of cognitive deficits in schizophrenia
D Umbricht et al.
NEUROPSYCHOPHARMACOLOGY (2003)
The pharmacology of psilocybin
T Passie et al.
ADDICTION BIOLOGY (2002)
Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man
F Hasler et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2002)
Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers
D Umbricht et al.
BIOLOGICAL PSYCHIATRY (2002)
A systems model of altered consciousness: Integrating natural and drug-induced psychoses
FX Vollenweider et al.
BRAIN RESEARCH BULLETIN (2001)
EEG coherence in post-LSD visual hallucinations
HD Abraham et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2001)
分享论文
